Regenxbio RGNX
NASDAQ RGNX
$8.63 +0.94 (+12.22%)
As of: Nov 11, 2026 · 1:16 PM EST

Regenxbio (RGNX) Invested Capital (2014 - 2015)

Updated

Regenxbio's Invested Capital came in at $216.81 million for Q4 2015, compared with -$15.89 million a year earlier.

Analysis

Regenxbio (RGNX) Invested Capital (2014 - 2015) Analysis & Trends

  • Going back by year, Invested Capital was -$15.89 million in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 89.77 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 126.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 76.32 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 98.72 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 45.14 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 68.36 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 39.27 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 151.97 Bn
10 Regenxbio 508.48 Mn -228.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 216.81 Mn
Dec 31, 2014 -15.89 Mn
API Access

Regenxbio Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=RGNX&period=max&api_key=YOUR_API_KEY